Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HOWARD J RUBENSTEIN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1376598086
CMS profile
244149
Location
SARALAND, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,424.94

82 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,345.14 80
Gift $59.40 1
Education $20.40 1

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HOWARD J RUBENSTEIN

NPI 1376598086 · CMS profile ID 244149

Allopathic & Osteopathic Physicians / Family Medicine

SARALAND, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

82 matching records · $1,424.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 82 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 82.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
IDORSIA PHARMACEUTICALS US INC $18.6512/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942809281 CMS
Currax Pharmaceuticals LLC $13.7612/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925767985 CMS
IDORSIA PHARMACEUTICALS US INC $17.1511/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942816727 CMS
ABBVIE INC. $6.5211/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488407 CMS
ABBVIE INC. $14.8811/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488409 CMS
Novo Nordisk Inc $0.8911/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899061797 CMS
Novo Nordisk Inc $5.3511/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899061805 CMS
Novartis Pharmaceuticals Corporation $18.4611/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894303291 CMS
GlaxoSmithKline, LLC. $11.8411/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944925179 CMS
Kowa Pharmaceuticals America, Inc. $12.4811/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900438435 CMS
Novo Nordisk Inc $4.9511/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898964069 CMS
Novo Nordisk Inc $1.9611/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899014943 CMS
Merck Sharp & Dohme LLC $22.6910/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944501785 CMS
Lilly USA, LLC $15.0910/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918069805 CMS
Dexcom, Inc. $12.5010/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957295093 CMS
Biohaven Pharmaceutical Holding Company Ltd. $17.7910/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923718069 CMS
Merck Sharp & Dohme LLC $16.1910/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944501383 CMS
Novo Nordisk Inc $5.2810/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899443511 CMS
Novo Nordisk Inc $1.8310/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899522927 CMS
Novo Nordisk Inc $0.6610/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899061915 CMS
ABBVIE INC. $29.8709/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488405 CMS
Novo Nordisk Inc $17.4509/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899522935 CMS
Novo Nordisk Inc $2.0509/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899443509 CMS
ABBVIE INC. $13.7709/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488403 CMS
Xeris Pharmaceuticals, Inc. $23.0609/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946478005 CMS
AstraZeneca Pharmaceuticals LP $117.6409/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915886641 CMS
Biohaven Pharmaceutical Holding Company Ltd. $11.9209/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923718067 CMS
Novo Nordisk Inc $2.2109/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898638103 CMS
Novo Nordisk Inc $3.6409/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898638111 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.8709/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959655795 CMS
ABBVIE INC. $11.2408/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488401 CMS
ABBVIE INC. $11.4208/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488399 CMS
Novo Nordisk Inc $14.2308/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898916736 CMS
Amgen Inc. $14.9708/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939282619 CMS
Amgen Inc. $13.0908/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939282615 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.1708/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960006865 CMS
ABBVIE INC. $5.3007/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488397 CMS
Bayer HealthCare Pharmaceuticals Inc. $13.4407/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930254253 CMS
AstraZeneca Pharmaceuticals LP $12.6007/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915419723 CMS
ABBVIE INC. $9.6307/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488395 CMS
Novo Nordisk Inc $2.2607/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898916729 CMS
Novo Nordisk Inc $4.8207/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899014951 CMS
ABBVIE INC. $18.8307/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488393 CMS
Lilly USA, LLC $17.8907/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918038157 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.3307/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959696939 CMS
AstraZeneca Pharmaceuticals LP $12.6106/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915603583 CMS
Dexcom, Inc. $12.5006/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957295095 CMS
ABBVIE INC. $22.5406/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488387 CMS
ABBVIE INC. $1.0806/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488389 CMS
ABBVIE INC. $7.6406/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488391 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,704.05 108
PY2020 $792.39 63
PY2021 $1,250.93 61
PY2022 $1,424.94 82
PY2023 $2,008.26 62
PY2025 $1,028.79 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $290,410.38 20
PY2024 Principal investigator $582,175.45 67
PY2023 Principal investigator $178,596.47 28
PY2022 Principal investigator $323,131.01 30
PY2021 Principal investigator $410,276.56 30
PY2020 Recipient $1,694.65 7
PY2020 Principal investigator $897,181.33 26
PY2019 Principal investigator $623,481.03 21

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

21 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 CIPLA USA INC. $300.00 11/27/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712619
Principal investigator 1 CIPLA USA INC. $7,127.90 11/12/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712707
Principal investigator 1 CIPLA USA INC. $3,950.00 11/12/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712709
Principal investigator 1 CIPLA USA INC. $3,007.22 10/31/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694717047
Principal investigator 1 CIPLA USA INC. $20.00 10/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS - RESEARCH
U-FS-MU-AS3120 No dispute reported 06/30/2026 694710301
Principal investigator 1 CIPLA USA INC. $24.00 10/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS - RESEARCH
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712729
Principal investigator 1 PFIZER INC. $158,610.84 10/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671665745
Principal investigator 1 CIPLA USA INC. $7,200.67 07/25/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694711813
Principal investigator 1 CIPLA USA INC. $16.80 07/23/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS - RESEARCH
U-FS-MU-AS3120 No dispute reported 06/30/2026 694714843
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $27.44 07/11/2019 Non-covered Recipient Entity
THE CTR FOR CLINICAL TRIALS INC
Exercise capacity study in HFpEF No dispute reported 06/30/2026 704143379
Principal investigator 1 CIPLA USA INC. $160.55 06/18/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694718023
Principal investigator 1 PFIZER INC. $7,075.00 06/17/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671622799
Principal investigator 1 PFIZER INC. $25,116.83 06/03/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671622783
Principal investigator 1 AstraZeneca UK Limited $3,997.00 05/20/2019 Non-covered Recipient Entity
Elias Research Associates Llc
A 26 Week Multicenter Randomized Placebo Controlled Double Blind Parallel Group Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus who are between 10 and below 18 years of age No dispute reported 06/30/2026 685000063
Principal investigator 1 PFIZER INC. $7,100.00 04/30/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671622797
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $283,588.06 04/10/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED, PARALLEL-GROUP TRIAL EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF CENTANAFADINE SUSTAINED-RELEASE TABLETS IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER TRIAL 405-201-00013 No dispute reported 06/30/2026 696053981
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $68,936.35 04/10/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
AN OPEN-LABEL, 52-WEEK, MULTICENTER TRIAL EVALUATING THE LONG-TERM SAFETY AND TOLERABILITY OF CENTANAFADINE SUSTAINED-RELEASE TABLETS IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER No dispute reported 06/30/2026 696053995
Principal investigator 1 PFIZER INC. $48.00 02/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671637795
Principal investigator 1 PFIZER INC. $2,395.90 01/03/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671695415
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $44,730.47 01/02/2019 Non-covered Recipient Entity
Elias Research Associates LLC
Exercise capacity study in HFrEF No dispute reported 06/30/2026 704143421
Principal investigator 1 PFIZER INC. $48.00 01/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671637793